Clinical trial
ALGRX 4975 After Total Knee Replacement
NCT00132392 · AlgoRx Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00132392 |
|---|---|
| Title | ALGRX 4975 After Total Knee Replacement |
| Official title | A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of ALGRX 4975 in Subjects After Total Knee Arthroplasty |
| Lead sponsor | AlgoRx Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Arthroplasty, Replacement, Knee, Knee Injuries |
| Intervention type | Drug |
| Interventions | ALGRX 4975 |
| Enrollment | 40 |
| Start date | Jul 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Aug 22, 2005 |
| Last update posted | Dec 20, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: